Antiphospholipid antibodies and malignancies

Autoimmunity Reviews

Volumn 9, Issue 4, 2010, Pages 200-202

  Tincani, A ^a   Taraborelli, M ^a   Cattaneo, R ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Cancer; Catastrophic antiphospholipid syndrome; Thrombosis

Indexed keywords

ALPHA INTERFERON; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER RISK; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; NEOPLASM; NONHODGKIN LYMPHOMA; PREVALENCE; REVIEW; SOLID TUMOR; THROMBOPHILIA; THROMBOSIS;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; DISEASE PROGRESSION; HUMANS; NEOPLASMS; PREVALENCE; PROGNOSIS; RISK FACTORS; THROMBOSIS;

EID: 73649097234     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.04.001     Document Type: Review

References (30)

1. Schulman S., and Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N Engl J Med 342 26 (2000) 1953-1958
2. Dogan M., and Demirkazik A. Venous thromboembolism in patients with cancer and its relationship to the coagulation cascade and vascular endothelial growth factor. Support Cancer Ther 3 1 (2005) 28-34
3. Lip G.Y.H., Chin B.S.P., and Blann A.D. Cancer and the prothrombotic state. Lancet Oncol 3 1 (2002) 27-34
4. Falanga A., and Rickles F.R. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Hemost 25 2 (1999) 173-182
5. Pham C., and Shen Y. Antiphospholipid antibodies and malignancy. Hematol Oncol Clin North Am 22 1 (2008) 121-130
6. Battistelli S., Stefanoni M., Petrioli R., Genovese A., Dell'Avanzato R., Donati G., et al. Antiphospholipid antibodies and acute-phase response in non-metastatic colorectal cancer patients. Int J Biol Markers 23 1 (2008) 31-35
7. Tincani A., Meroni P.L., Brucato A., Zanussi C., Allegri F., Mantelli P., et al. Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 3 4 (1985) 321-326
8. Pierangeli S.S., Liu X.W., Barker J.H., Anderson G., and Harris E.N. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 74 5 (1995) 1361-1367
9. Levine J.S., Branch D.W., and Rauch J. The antiphospholipid syndrome. N Engl J Med 346 10 (2002) 752-763
10. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 2 (2006) 295-306
11. Zuckerman E., Toubi E., Golan T.D., Rosenvald-Zuckerman T., Sabo E., Shmuel Z., et al. Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy. Br J Cancer 72 2 (1995) 447-451
12. Pusterla S., Previtali S., Marziali S., Cortelazzo S., Rossi A., Barbui T., et al. Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. Hematol J 5 4 (2004) 341-346
13. Reinstein E., and Shoenfeld Y. Antiphospholipid syndrome and cancer. Clin Rev Allergy Immunol 32 2 (2007) 184-187
14. Becker J.C., Winkler B., Klingert S., and Bröcker E.B. Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer 73 6 (1994) 1621-1624
15. Sawamura M., Yamaguchi S., Murakami H., Amagai H., Matsushima T., Tamura J., et al. Multiple autoantibody production in a patient with splenic lymphoma. Ann Hematol 68 5 (1994) 251-254
16. Vogt E., Ng A.K., and Rote N.S. Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol 177 4 (1997) 964-972
17. Thiagarajan P., Shapiro S.S., and De Marco L. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest 66 3 (1980) 397-405
18. Miesbach W., Scharrer I., and Asherson R. Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin Rheumatol 25 6 (2006) 840-844
19. Grossman A., Gafter-Gvili A., Green H., Ben Aharon I., Stemmer S.M., Molad Y., et al. Severe digital ischemia - a presenting symptom of malignancy-associated antiphospholipid syndrome. Lupus 17 3 (2008) 206-209
20. Genvresse I., Lüftner D., Späth-Schwalbe E., and Buttgereit F. Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma. Eur J Haematol 68 2 (2002) 84-90
21. Miesbach W., Scharrer I., and Asherson R.A. High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma. Clin Rheumatol 26 1 (2007) 95-97
22. Yoon K.H., Wong A., Shakespeare T., and Sivalingam P. High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis. Lupus 12 2 (2003) 112-116
23. de Meis E., Monteiro R.Q., and Levy R.A. Lung adenocarcinoma and antiphospholipid antibodies. Autoimmun Rev (2009) [Electronic publication ahead of print]
24. de Laat B., Wu X., van Lummel M., Derksen R.H.W.M., de Groot P.G., and Rand J.H. Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 109 4 (2007) 1490-1494
25. Finazzi G. The Italian registry of antiphospholipid antibodies. Haematologica 82 1 (1997) 101-105
26. Gómez-Puerta J.A., Cervera R., Espinosa G., Aguiló S., Bucciarelli S., Ramos-Casals M., et al. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 35 5 (2006) 322-332
27. Endler G., Marsik C., Jilma B., Schickbauer T., Vormittag R., Wagner O., et al. Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary report. Clin Chem 52 6 (2006) 1040-1044
28. Cervera R., Khamashta M.A., Shoenfeld Y., Camps M.T., Jacobsen S., Kiss E., et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1,000 patients. Ann Rheum Dis (2008) [Electronic publication ahead of print]
29. Asherson R.A., Cervera R., Piette J.C., Font J., Lie J.T., Burcoglu A., et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine 77 3 (1998) 195-207
30. Miesbach W., Asherson R.A., Cervera R., Shoenfeld Y., Gomez Puerta J., Bucciarelli S., et al. The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmun Rev 6 2 (2006) 94-97